Article Details

Nectero Medical: $96 Million Secured To Develop Novel Therapies To Treat Aneurysmal Disease

Retrieved on: 2024-04-16 16:17:56

Tags for this article:

Click the tags to see associated articles and topics

Nectero Medical: $96 Million Secured To Develop Novel Therapies To Treat Aneurysmal Disease. View article details on hiswai:

Excerpt

This round was led by Norwest Venture Partners and included large investments from Boston Scientific Corporation, BioStar Capital, Cadence ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up